ArticleTransplantation and cellular therapy2023

Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.

Ellen Fraint et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.